Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant melan-A/MART-1 antigenic peptide

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6956-6962

  Valmori, Danila ^a   Gervois, Nadine ^b   Rimoldi, Donata ^c   Fonteneau, Jean Francois ^b   Bonelo, Anilza ^d   Liénard, Danielle ^a   Rivoltini, Licia ^e   Jotereau, Francine ^b   Cerottini, Jean Charles ^a,c   Romero, Pedro ^a,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b INSERM   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSIDAD DEL VALLE   (Colombia)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; HLA ANTIGEN; PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; BINDING AFFINITY; CROSS REACTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPH NODE CELL; MELANOMA; PRIORITY JOURNAL; RESTRICTION MAPPING;

ALLELES; AMINO ACID SUBSTITUTION; ANTIGENS, NEOPLASM; CELL LINE, TRANSFORMED; CELLS, CULTURED; GENE REARRANGEMENT, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032534581     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Romero, P. 1996. Cytolytic T lymphocyte responses of cancer patients to tumor-associated antigens. Springer Semin. Immunopathol. 18:185.
2. Robbins, P. F., and Y. Kawakami. 1996. Human tumor antigens recognized by T cells. Curr. Opin. Immunol. 8:628.
3. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515.
4. Coulie, P. G., V. Brichard, A. Van Pel, T. Wölfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J. P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35.
5. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347.
6. Spagnoli, G. C., C. Schaefer, T. E. Willimann, T. Kocher, A. Amoroso, A. Juretic, M. Zuber, U. Luscher, F. Harder, and M. Heberer. 1995. Peptide-specific CTL in tumor-infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and tyrosinase genes: a study in an unselected group of HLA-A2.1 positive patients. Int. J. Cancer 64:309.
7. Rivoltini, L., Y. Kawakami, K. Sakaguchi, S. Southwood, A. Sette, P. F. Robbins, F. M. Marincola, M. L. Salgaller, J. R. Yannelli, E. Appella, et al. 1995. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154:2257.
8. Stevens, E. J., L. Jacknin, P. F. Robbins, Y. Kawakami, M. El Gamil, S. A. Rosenberg, and J. R. Yannelli. 1995. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. J. Immunol. 154:762.
9. + cytotoxic T lymphocytes. J. Exp. Med. 181:363.
10. Romero, P., N. Gervois, J. Schneider, P. Escobar, D. Valmori, C. Pannetier, A. Steinle, T. Wölfel, D. Liénard, V. Brichard, et al. 1997. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201 restricted Melan-A/ MART-1 antigenic peptide in melanoma. J. Immunol. 159:2366.
11. Valmori, D., J. F. Fonteneau, C. Marañón Lizana, N. Gervois, D. Liénard, D. Rimoldi, C. V. Jongeneel, F. Jotereau, J. C. Cerottini, and P. Romero. 1998. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs. J. Immunol. 160:1750.
12. Wölfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K. H. Meyer zum Büschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24:759.
13. + clones derived from human melanoma-infiltrating lymphocytes. Eur. J. Immunol. 22:1795.
14. Skipper, J. C. A., R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Van Pel, Y. Chen, J. Shabanowitz, T. Wölfel, C. L. Slingluff, Jr., T. Boon, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183:527.
15. van der Burg, S. H., M. J. W. Visseren, R. M. P. Brandt, W. M. Kast, and C. J. M. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156:3308.
16. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
17. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
18. Wölfel, T., J. Schneider, K. H. Meyer zum Buschenfelde, H. G. Rammensee, O. Rotzschke, and K. Falk. 1994. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int. J. Cancer 57:413.
19. + tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur. J. Immunol. 24:1966.
20. Gervois, N., Y. Guilloux, E. Diez, and F. Jotereau. 1996. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J. Exp. Med. 183:2403.
21. Hemmer, B., B. T. Fleckenstein, M. Vergelli, G. Jung, H. MacFarland, R. Martin, and K. H. Wiesmüller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1651.
22. (27-35). J. Exp. Med. 184:647.
23. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.